Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NBPE - Transaction in Own Shares
-
Transaction in Own Shares
-
Wet Concentrator Plant A Project Update
-
Sampo plc’s share buybacks 10 September 2025
-
TomTom Orbis Maps reaches 2 million charging points enabling seamless EV navigation
-
Bigbank AS Results for August 2025
-
Start of construction on Liven's Iseära and Peakorter projects
-
Technip Energies to acquire Ecovyst’s Advanced Materials & Catalysts business
-
Technip Energies to acquire Ecovyst’s Advanced Materials & Catalysts business
-
Start of Day Message
-
IDEX Biometrics launches new product portfolio for payment and access solutions
-
Wereldhave strengthens Investor Relations with appointment of Fleur van der Erve
-
Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
-
ISS signs large contract with Australian Department of Defence
-
ISS signs large contract with Australian Department of Defence
-
Fort Belknap Indian Community Advances Broadband Project with Support from Spy Ego Media
-
Law Offices of Richard C. McConathy Opens Frisco Office to Expand Services in Collin and Denton Counties
-
Bioptimus Assembles Elite Scientific Advisory Board to Build Next-Gen AI Models for Biology
-
PITAKA Redefines iPhone 17 Cases with Fusion Weave – LightRipple and World’s First PitaTap™ Technology
-
LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering
-
Barrick Announces Sale of Hemlo for Up To $1.09 Billion
-
Q2 Metals Clarifies Technical Disclosure on Initial Exploration Target at the Cisco Lithium Project in James Bay, Quebec, Canada
-
Tellus Power Globe Holding Limited Introduces Two New 600kW DC Fast Chargers to Improve Utilization and Reduce Cost of Ownership
-
Metalsource announces CHANGE OF DIRECTORS
-
London, ON; A catalyst for national technology sector growth
-
Salem Media Statement on the Assassination of Charlie Kirk
-
Award-Winning Documentary “Hidden Battles Destigmatizing Mental Illness” to Premiere in Lincoln, Nebraska on October 14, 2025
-
AM Best Reaffirms A (Excellent) Financial Strength Rating for Mutual Insurance Company of Arizona
-
HPU Celebrates Grand Opening of New Dental School Building
-
Holley Performance Brands Announces Pricing of a Secondary Offering by Selling Stockholder
-
Lynch Carpenter Investigates Claims in Retina Group of Florida Data Breach
-
CAPREIT Completes Sale of International Plaza to Nch’ḵaý Development Corporation
-
Opendoor Names Kaz Nejatian as CEO; Founders Rabois and Wu Rejoin Board
-
DTC Launches Sentry 6161 Mesh MANET Radio
-
Twin Peaks Strengthens Support for Veterans, Military, and First Responders with New Lunch Campaign
-
Republic of Colombia Announces Pricing of its New Bonds Offering
-
Highland Copper Completes Environmental Mitigation Program Demonstrating Benefit of Concurrent Reclamation at Copperwood Project
-
Maui Land & Pineapple Company, Inc. Announces Strategic Evaluation of Water Source and Transmission Assets
-
Maui Land & Pineapple Company, Inc. Announces Strategic Evaluation of Water Source and Transmission Assets
-
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
-
SAVE THE DATE: NOVAGOLD 2025 Third Quarter Report, Conference Call and Video Webcast
-
ZVOX Set to Redefine Enterprise Customer Engagement with AI Voice Agents
-
THOR Industries Announces Date for its Fiscal 2025 Fourth Quarter Earnings Release
-
Currency Exchange International Reports Third Quarter 2025 Results
-
18th Annual Associa Cares Vendor Fair Raises More Than $500,000 to Support Families in Crisis
-
Major Drilling Announces Results of Annual Meeting of Shareholders
-
Fusion Fuel Green PLC Announces Highlights of First Half 2025 Financial Results and Corporate Developments
-
Enlightify Inc. Notifies New York Stock Exchange of Intent to Cure Price Deficiency
-
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
-
Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate

